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First published August 18, 2010; doi:10.1152/ajpregu.00326.2010.—The
aim of this study was to investigate dynamic autoregulation of renal
blood flow (RBF) in ANG II-infused rats and the influence of
high-NaCl intake. Sprague-Dawley rats received ANG II (250
ng·kg1·min1 sc) or saline vehicle (sham) for 14 days after which
acute renal clearance experiments were performed during thiobutabar-
bital anesthesia. Rats (n  8–10 per group) were either on a normal
(NNa; 0.4% NaCl)- or high (HNa; 8% NaCl)-NaCl diet. Separate
groups were treated with 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-
oxyl (tempol; 1 M in drinking water). Transfer function analysis from
arterial pressure to RBF in the frequency domain was used to examine
the myogenic response (MR; 0.06–0.09 Hz) and the tubuloglomerular
feedback mechanism (TGF; 0.03–0.06 Hz). MAP was elevated in
ANG II-infused rats compared with sham groups (P  0.05). RBF in
ANG II HNa was reduced vs. sham NNa and sham HNa (6.0  0.3
vs. 7.9  0.3 and 9.1  0.3 ml·min1·g kidney wt1, P  0.05).
transfer function gain in ANG II HNa was significantly elevated in the
frequency range of the MR (1.26  0.50 dB, P  0.05 vs. all other
groups) and in the frequency range of the TGF (0.02  0.50 dB,
P  0.05 vs. sham NNa and sham HNa). Gain values in the
frequency range of the MR and TGF were significantly reduced by
tempol in ANG II-infused rats on HNa diet. In summary, the MR and
TGF components of RBF autoregulation were impaired in ANG II
HNa, and these abnormalities were attenuated by tempol, suggesting
a pathogenetic role for superoxide in the impaired RBF autoregulatory
response.
tubuloglomerular feedback; superoxide; myogenic response
HYPERTENSION IS A COMMON CAUSE of kidney injury and end-stage
renal disease and accelerates loss of kidney function in patients
with chronic kidney disease, regardless of the underlying
etiology (19). However, the risk of renal injury is variable, and
the pathophysiological mechanisms by which hypertension
causes renal parenchymal injury are complex and incompletely
understood (5, 13, 27, 28, 34). The renal blood flow (RBF)
autoregulatory response, mediated mainly by the myogenic
response (MR) and the tubuloglomerular feedback mechanism
(TGF), stabilizes RBF and glomerular filtration rate (GFR),
despite wide variations in arterial blood pressure (AP) (9, 23).
RBF autoregulation (RBFA) may also serve a protective func-
tion, particularly in hypertension, by preventing transmission
of systemic AP to the glomerular capillaries (2, 28). A role for
autoregulatory capacity as a determinant of vulnerability to
renal injury has been suggested in the 5/6 renal ablation model
in rats (4) and in genetic models characterized by impaired
RBFA (37, 38). In addition, treatment with dihydropyridine
calcium channel blockers, which interfere with RBFA by
impairing the MR, has been shown to increase the susceptibil-
ity to hypertensive glomerular injury in rats subjected to 5/6
nephrectomy (17).
Increased dietary NaCl has been shown to accelerate renal
injury in hypertension (1, 5, 32). However, the pathophysio-
logical mechanisms by which increased NaCl intake enhances
renal injury in hypertension are multiple and not fully eluci-
dated. Takenaka et al. (35) showed that preglomerular arte-
rioles in Dahl salt-sensitive rats, on a high-NaCl diet, exhibited
reduced myogenic responsiveness to increased AP, suggesting
a role for impaired RBFA as a cause of renal injury in this
model (35). In addition, several studies indicate that reactive
oxygen species contribute to renal injury in NaCl-sensitive
forms of hypertension (18, 36). In the present study, we
hypothesized that the combined influence of ANG II, and a
high-NaCl intake, could lead to impaired autoregulation of
RBF in this hypertensive model. In addition, we speculated that
superoxide (O2·), a reactive oxygen species whose production
is stimulated by ANG II (15, 27), could be involved in the
abnormal RBF autoregulatory response. To examine this hy-
pothesis we used transfer function (TF) analysis that enabled us
to analyze the separate contributions of the MR and the TGF
mechanism to dynamic autoregulation of RBF in chronically
ANG II-infused Sprague-Dawley rats on either a normal or a
high-NaCl diet.
METHODS
General Procedures
Male Sprague-Dawley rats (Harlan, Horst, The Netherlands)
weighing 300 g were used. All experiments were approved by the
regional ethics committee in Gothenburg, Sweden. Rats had free
access to rat chow and tap water and were kept in rooms with a
controlled temperature of 24–26°C and a 12:12-h dark-light cycle.
Chemicals were from Sigma (St. Louis, MO), if not stated otherwise.
Protocol
Rats received ANG II (250 ng·kg1·min1 sc) or isotonic saline
vehicle (sham) via osmotic minipumps (Alzet model 2002) for 14
days, after which acute experiments were performed. Rats were either
on a normal (NNa, 0.4% NaCl)- or high (HNa, 8% NaCl)-NaCl diet
(Lantmännen, Sweden), creating the following groups: 1) sham NNa
(n 10); 2) sham HNa (n 9); 3) ANG II NNa (n 9); and (4) ANG
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II HNa (n  8). In separate groups, the membrane-permeable super-
oxide dismutase mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-
oxyl (tempol) was administered in the drinking water (1 M ) through-
out the 14-day period: 5) sham NNatempol (n  8); 6) sham
HNatempol (n  10); 7) ANG II NNatempol (n  10); and 8)
ANG II HNatempol (n  10). Tempol administered by drinking
water in this concentration has been demonstrated to significantly
reduce AP and markers of oxidative stress in several hypertensive rat
models (15, 18, 36) including in ANG II HNa (30).
Surgical Preparation and Measurements
Rats were anaesthetized with thiobutabarbital (Inactin; 120 mg/kg
ip), placed on a heating table, and surgically prepared for renal
clearance experiments as previously described (29). An AP catheter
was inserted via the femoral artery and was connected to a pressure
transducer (Smiths Medical, Kirchseeon, Germany) for monitoring of
arterial pressure [AP; pulsatile and mean (MAP)] and heart rate using
a data acquisition program (MP 150; Biopac Systems, Santa Barbara,
CA). The left kidney was exposed by a flank incision and immobilized
in a plastic cup. The left ureter was catheterized for urine collection.
Rectal and kidney temperatures were kept at 37°C. A perivascular
ultrasonic transit-time flow probe (0.7 VB) was placed around the left
renal artery and connected to a flowmeter (model T206, filter 100 Hz)
for measurement of RBF (Transonic Systems, Ithaca, NY). GFR was
determined by measuring renal 51Cr-EDTA clearance (Amersham
Laboratories, Buckinghamshire, UK) as described (29). Blood was
sampled at the start and completion of two consecutive 20-min urinary
clearance periods, and mean values of plasma radioactivity were used
to calculate GFR. Arterial blood samples (0.3 ml) were replaced by
equivalent volumes of 4% BSA in isotonic saline. Rats were infused
with 10 ml·kg1·h1 of isotonic saline throughout. Rats were killed
by an overdose of pentobarbital sodium, and the kidneys were
excised and weighed. Kidneys were immersion-fixed in parafor-
maldehyde and prepared for histological analyses. Renal vascular
resistance (RVR) was calculated as MAP (mmHg)/RBF (ml·min1·g
kidney wt1), and filtration fraction (FF) was estimated as GFR/RBF.
TF Analysis
Data used to examine the dynamic relationship between AP and
RBF, i.e., dynamic autoregulation of RBF, were sampled at 62.5 Hz
yielding 75,000 data points for each 20-min period (150,000 data
points for the two 20-min periods). Processing of AP and RBF data
was performed off-line by using previously developed software rou-
tines written for Matlab 7.14 (The MathWorks, Natick, MA). After
subtracting the mean value from the data files, they were digitally
low-pass filtered (3.0 Hz cut-off frequency, finite-impulse response,
order 50) and then resampled to a rate of 6.25 Hz. These 6.25-Hz data
files were split into blocks of 2,048 data points, yielding a frequency
discrimination of 0.003 Hz. Power spectral density (PSD) of AP and
RBF was calculated, as described (10, 11). The TF spectra were
calculated from AP (input) and RBF (output). The TF gain was taken
as the quotient of the cross spectrum of input and output divided by
the power spectrum of the input (10, 11). Coherence is a frequency
domain estimate of a linear correlation (i.e., squared coherence, akin
to coefficient of determination) between two signals indicating the
degree to which the variance in one signal can be explained by a linear
operation on the other signal (10, 11). The coherence spectra were
calculated from AP (input) and RBF (output). The coherence function
was taken as the quotient of the square of the cross spectrum of input
and output divided by the product of the power spectral densities of
AP and RBF (10, 11). These algorithms involved a Hanning window
with 50% overlap of the blocks (12 blocks in the two 20-min
recording periods). To permit comparison among rats, the TF gain
(magnitude) values over the frequency range have been normalized to
the mean value of the renal vascular conductance for the entire data
set. After conversion of the normalized TF gain values into decibels
[20 log (gain)], a mean spectrum was calculated from the consecutive
spectra in each rat, and these were subsequently averaged for all rats.
The TF gain corresponds to the ratio of the amplitude of normalized
fluctuations in RBF divided by those of AP. In the presence of RBFA,
fluctuations of RBF are attenuated vs. those of AP causing the TF gain
to be negative. Thus, positive TF gain values indicate impaired RBFA
(9, 23). Phase and coherence spectra were similarly calculated and
averaged. Data over the range of frequencies for the MR (0.08–0.18)
and the TGF mechanism (0.03–0.06) were analyzed (9, 23). The slope
of gain reduction in the frequency range of the MR was determined by
least squares fitting of the linear region of gain reduction, and the
phase peak was estimated as the average phase value within the same
frequency interval. In addition, to assess the contribution of the MR to
RBFA, mean gain values in the frequency range of 0.06 -0.09 Hz were
used to minimize corruption by TGF (0.06 Hz) and myogenic
transients (0.09 Hz) (38). To assess the effect of filtering at either 30
Hz or 100 Hz, we made two consecutive recording periods in a single
rat with 30 Hz filter/62.5 Hz sampling followed by 100-Hz filter/
62.5-Hz sampling. Each of these data sets was subjected to the same
processing and analysis as described above. The results showed that
over the frequency range of interest (0.01–1.0 Hz) there were no
significant differences in PSD for AP and RBF or in TF gain, phase,
or coherence in the TGF (0.03–0.06 Hz) or MR (0.08–0.18 Hz)
frequency ranges. To determine the threshold for coherence above
which it exceeds zero with a certain significance level, we used the
method described by Koopmans (26), which depends on the total
number of samples, the total number of blocks, and the nature of the
tapering window. In this study with large sample numbers, coherence
values  0.1 are significantly different from zero at P  0.001.
Kidney Histology
Kidneys were processed using routine techniques, and 3-m thick
transverse sections through the hilar area were prepared and stained
with hematoxylin and eosin, periodic acid-Schiff, and elastin-vanG-
ieson’s. Histopathological changes were scored semiquantitatively
(0–3) by an investigator (N. Marcussen) blinded to treatment group.
The scores: 0, when no pathologic changes were present; 1, when few
of the structures showed changes and the changes were mild; 2, when
moderate changes were present; and 3, when severe changes were
present in the structures under investigation. For glomerular parame-
ters, the percentage of pathologically altered glomeruli was estimated.
Cortical arteries (i.e., interlobar, arcuate, and interlobular arteries) and
arterioles (i.e., afferent and efferent arterioles) were scored separately.
Statistical Analysis
All values are means  SE. Analyses were performed using
one-way ANOVA. Normality was tested with the Shapiro-Wilk test,
and equality of variances was assessed with the Levene’s test. If data
were not normally distributed or had unequal variances, Kruskal-
Wallis one-way ANOVA on ranks was used. An unpaired t-test and
Mann-Whitney U-test was used when appropriate. Bonferroni correc-
tions were made for multiple comparisons. To reduce the number of
comparisons, no statistical analyses were made between ANG II NNa
and sham HNa. Group ANG II NNatempol was compared with
ANG II NNa and sham NNa, and group ANG II HNatempol was
compared with ANG II HNa and sham HNa. In all cases, a P value 
0.05 was considered statistically significant. The statistical software
SPSS 17.0 (SPSS, Chicago, IL) was used.
RESULTS
Kidney Function and Renal Hemodynamics
Effects of NaCl intake and ANG II. Group sham HNa
showed elevated RBF and reduced FF compared with sham
rats on a normal NaCl diet, sham NNa (Table 1). In addition,
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left ventricular weight (LVW) was elevated in sham HNa
compared with sham NNa, although there was no significant
difference between groups in MAP (Table 1).
In ANG II-infused rats on a normal NaCl diet (ANG II NNa)
MAP, LVW, and RVR were increased compared with sham
NNa (Table 1). Similarly, MAP, LVW, and RVR were signif-
icantly elevated and RBF was reduced, in group ANG II HNa
compared with both sham NNa and sham HNa (Table 1). In
addition, GFR and FF were significantly elevated in ANG II
HNa vs. sham HNa (Table 1). There were no statistically
significant differences between groups ANG II NNa and ANG
II HNa in MAP, LVW, RBF, or GFR (Table 1). However,
RVR, FF, urine output, and absolute and fractional urinary
sodium excretion were elevated in ANG II HNa compared with
ANG II NNa (Table 1).
Effects of tempol. Tempol had no statistically significant
effects on any of the investigated variables in sham NNa (data
not shown). In sham HNa, tempol significantly reduced RBF
(7.7  0.3 vs. 9.1  0.3 ml·min1·g kidnet wt1, in groups
sham HNatempol and sham HNa, respectively, P  0.05)
and increased RVR (15.1  0.5 vs. 13.2  0.5 ml·min1·g
kidnet wt1, in groups sham HNatempol and sham HNa,
respectively, P  0.05). There were no statistically significant
differences between groups sham HNatempol and sham HNa
in MAP, GFR, or any of the other investigated variables (data
not shown).
In ANG II NNatempol, GFR was reduced compared with
ANG II NNa, but tempol had no significant effects on any of
the other variables (Table 1). In ANG II HNatempol MAP,
heart rate (HR), GFR, and FF were reduced compared with
ANG II HNa (Table 1).
TF Analysis
Effects of high-NaCl diet. In the frequency range of the MR
(0.08–018 Hz), the normal positive-to-negative transition in
gain (with decreasing frequency) and the slope of gain reduc-
tion, were comparable in groups sham NNa and sham HNa
(Table 2, Figs. 1 and 2). The positive-to-negative transition in
gain in both sham groups was associated with the expected
local maximum increment in phase, indicating active MR
(Figs. 1 and 2). In sham HNa, gain values in the TGF fre-
quency range (0.03–0.06 Hz) were comparable to those in
sham NNa (Table 2, Figs. 1 and 2).
Effects of ANG II. In ANG II NNa, gain values reflecting the
regulatory action of the MR (0.06–0.09 Hz) were not signif-
icantly different from those in sham NNa, and there was a clear
transition in gain from positive to negative values (Table 2,
Figs. 1 and 2). In the frequency range of the MR (0.08–018
Hz), the slope of gain reduction and the associated local
maximum in phase were reduced in ANG II NNa compared
with sham NNa (Table 2, Figs. 1 and 2). In the TGF frequency
range, gain values in ANG II NNa were comparable to those in
sham NNa (Table 2, Figs. 1 and 2).
Effects of ANG IIhigh-NaCl diet. In the frequency range of
the MR the normal transition in gain from positive to negative
values did not occur in ANG II HNa, and the corresponding
local maximum in phase was missing, indicating an impaired
Table 1. Kidney function and renal hemodynamics
Sham NNa Sham HNa Ang II NNa Ang II NNa  Tempol Ang II HNa Ang II HNa  Tempol
Number 10 9 9 10 8 10
Body weight, g 300  15 318  9 283  10 297  11 281 16 267  9f
MAP, mmHg 118  3 120  3 146  3a 149  5e 156  4a,b 139  5d,f
LVW, g/kg body wt 2.18  0.05 2.48  0.04c 2.81  0.09a 2.72  0.07e 2.87  0.09a,b 2.81  0.09f
Heart rate, beats/min 379  6 359  6 387  6 376  13 392 10b 339  10d
GFR, ml  min1  g kidney wt1 1.15  0.06 1.00  0.08 1.28 0.08 0.96  0.07d 1.40  0.04b 0.85  0.04d
RBF, ml  min1  g kidney wt1 7.9  0.3 9.1  0.3c 7.1  0.4 6.3  0.5e 6.0  0.3a,b 5.0  0.3f
RVR, mmHg/[ml  min1  g kidney wt1] 15.1  0.6 13.2  0.5 20.9 1.2c 24.9  2.5e 26.4  1.6c 29.5  3.0f
FF, GFR/RBF, % 14.7  1.0 10.7  0.8a 18.2  1.2 16.0  1.7 23.5 0.7c 17.6  1.2d,f
UV, l  min  g KW 4.36  0.74 5.69  0.91 8.30 2.31 16.25  5.29e 32.80  5.85c 23.02  5.90f
UNaV, mol/min 0.62  0.15 2.13  0.42c 0.46  0.09 1.30  0.49 6.08 0.88c 4.23  1.19
FENa,% 0.36  0.09 1.42  0.19c 0.26  0.05 0.94  0.30 3.07 0.47c 3.45  0.90
Data are means  SE of two 20-min clearance periods in thiobutabarbital anesthetized rats (see METHODS). NNa, normal NaCl; HNa, high NaCl; MAP, mean
arterial pressure; LVW, left ventricular weight; GFR, glomerular filtration rate; RBF, renal blood flow; RVR, renal vascular resistance; FF, filtration fraction;
UV, urine flow rate; FENa, fractional urinary excretion of Na; UNaV, urinary Na excretion. aP  0.05 vs. sham NNa, bP  0.05 vs. sham HNa, cP  0.05 vs.
all other groups excluding groups with tempol, dP  0.05 vs. corresponding Ang II group without tempol, eP  0.05 vs. sham NNa, and fP  0.05 vs. sham
HNa.
Table 2. Characteristics of the transfer function between arterial pressure and renal blood flow
Sham NNa Sham HNa Ang II NNa Ang II NNa  Tempol Ang II HNa Ang II HNa  Tempol
Number 10 9 9 10 8 10
Gain, 0.03-0.06 Hz, dB 3.45  0.63 5.84  0.65 2.68  0.98 2.42  0.66 0.02  0.50a,b 2.87  1.04d,f
Gain, 0.06-0.09 Hz, dB 3.17  0.50 5.55  0.92 2.56  1.24 1.80  0.68 1.26  0.50c 2.22  1.03d,f
Gain, slope 0.08-0.18Hz,
dB/decade 18.60  1.68 18.62 2.05 9.22  3.05a 8.45  1.88e 2.33  1.11a,b 8.30  2.92f
Phase, 0.08-0.18 Hz, rad 0.58  0.37 0.61 0.06 0.41  0.07a 0.40  0.06e 0.18  0.03c 0.39  0.10f
Data are means SE. Gain values in the frequency range 0.03–0.06 Hz correspond to the TGF mechanism and values in the range 0.06–0.09 Hz reflect the regulatory
action of the MR (see METHODS). aP  0.05 vs. Sham NNa, bP  0.05 vs. Sham HNa, cP  0.05 vs. all other groups excluding groups with tempol, dP  0.05
vs. corresponding Ang II group without tempol, eP  0.05 vs. Sham NNa, and fP  0.05 vs. Sham HNa.
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MR (Figs. 1 and 2). Gain values in the frequency range of
0.06–0.09 Hz were significantly elevated in ANG II HNa
compared with sham NNa, sham HNa, and ANG II NNa (Table
2). In the TGF frequency range, gain values in ANG II HNa
were significantly elevated compared with sham NNa and
sham HNa (Table 2, Figs. 1 and 2).
Effects of tempol. Tempol had no statistically significant
effects on dynamic RBFA assessed by TF analysis in groups
sham NNa and sham HNa (data not shown). Similarly, in the
ANG II NNatempol group, tempol did not significantly
affect TF variables, including the slope of gain reduction and
phase values, in the frequency range of the MR (Table 2, Fig. 3).
However, in ANG II HNatempol, there was a clear transition
in gain from positive to negative values in the frequency range
of the MR, and this was associated with a local maximum in
phase indicating an active MR (Fig. 4). Consequently, gain
values were significantly reduced in ANG II HNatempol
compared with ANG II HNa in the frequency range of both the
MR (0.06–0.09 Hz) and the TGF (0.03–0.06 Hz), (Table 2,
Fig. 4). Nevertheless, TF analysis variables remained signifi-
cantly different in ANG II HNatempol compared with sham
HNa in the frequency range of both the MR and the TGF
(Table 2).
Kidney Histology
There were no statistically significant differences between
groups in tubulointerstitial changes (i.e., inflammation, fibro-
sis, and tubular dilatation) or glomerular abnormalities (i.e.,
glomerular size variation, ischemia, focal segmental glomeru-
losclerosis, and global glomerulosclerosis) (data not shown).
There was significant thickening of intimal and medial layers
and hyaline deposition/necrosis of cortical arteries in both
ANG II NNa and ANG II HNa compared with sham NNa (Fig.
5, Table 3). In addition, cortical arterioles (i.e., afferent and
efferent arterioles) showed significant hyperplasia and hyali-
nosis compared with sham (Fig. 5, Table 3). However, the
magnitude of arterial and arteriolar changes in ANG II NNa
and ANG II HNa were not significantly different, and tempol
had no significant effects on vascular abnormalities (Fig. 5,
Table 3). Notably, vascular changes in hypertensive animals
were generally mild and showed a focal distribution.
DISCUSSION
The main finding of the present study was that a high-NaCl
intake in chronically ANG II-infused rats resulted in a marked
impairment of the MR of RBFA. This abnormality was not
seen in sham HNa and was significantly more pronounced than
in ANG II NNa, indicating a synergistic effect of high-NaCl
intake and elevated ANG II. In addition, this abnormality in
RBFA in ANG II HNa was corrected by tempol, suggesting a
role for O2· in the impaired autoregulatory response.
In the frequency range of the MR, TF analysis showed a
reduced slope of gain reduction and a diminished phase peak in
ANG II NNa compared with sham NNa, indicating an impaired
MR. This result differs from a previous study in which dy-
namic RBFA was assessed in conscious dogs infused with
Fig. 2. Enlarged transfer function gain (top) and phase (bottom) in anesthetized
Sprague-Dawley rats after 14 days of ANG II (250 ng·kg1·min1 sc) or saline
vehicle (sham) infusion. Rats were on either an NNa or HNa diet (see
METHODS). In the frequency range of the mypgenic response (MR; 0.08 – 018
Hz), gain values showed a positive-to-negative transition in groups sham
NNa, sham HNa, and ANG II NNa. The positive-to-negative transition in
gain in these groups was associated with the expected local maximum in
phase, indicating active MR. In ANG II HNa, the positive-to-negative
transition in gain in the frequency range of the MR remained above 0 dB,
and the local maximum in phase was missing, indicating impaired MR.
Values are means  SE.
Fig. 1. Power spectral density (PSD) for arterial pressure (AP) and renal blood
flow (RBF) and transfer function gain, phase, and coherence in anesthetized
Sprague-Dawley rats after 14 days of ANG II (250 ng·kg1·min1 sc) or saline
vehicle (sham) infusion. Rats were on either a normal (NNa)- or a high
(HNa)-NaCl diet (see METHODS). Values are means  SE.
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ANG II to produce plasma ANG II levels within the physio-
logical range (24). These investigators found that ANG II did
not affect the efficiency of RBFA or the relative contribution of
the MR and TGF components (24). The discrepancy between
studies could be explained by marked differences in the exper-
imental protocols, as the potential difference between con-
scious and anesthetized animals. In addition, in our study
animals were hypertensive and infused with much higher ANG
II concentrations and for a longer duration. However, several
studies have demonstrated in experimental models closely
resembling ours that RBFA is impaired in chronically ANG
II-infused hypertensive animals (8, 21, 40) as well as in the
nonstenotic kidney of Goldblatt hypertensive rats (31). Most of
the studies on chronically ANG II-infused rats have been
performed using the in vitro blood-perfused juxtamedullary
nephron model in which responses of afferent arterioles to
step-wise changes in perfusion pressure were analyzed (8, 21,
40). In contrast, our study presents data on dynamic autoreg-
ulation of whole kidney RBF during spontaneous fluctuations
in AP in intact ANG II hypertensive animals. In addition, we
extend previous findings by suggesting that chronic ANG II
infusion selectively affects the MR component of RBFA in
animals on a normal NaCl intake.
The major finding in the present study was the much more
pronounced impairment in dynamic RBFA in ANG II HNa
compared with ANG II NNa. This abnormality in ANG II HNa
was characterized by an almost complete absence of a MR.
This synergistic effect of ANG II and high-NaCl intake on
dynamic RBFA represents a novel finding. One could hypoth-
esize that the impairment in RBFA, mainly in group ANG II
HNa, would make kidneys vulnerable primarily to reductions
in AP and not to glomerular hypertension, as RVR was mark-
edly elevated and RBF was reduced in these rats. However,
despite the reduction in RBF, GFR tended to be elevated in
ANG II HNa, and FF was significantly increased vs. the other
groups. These results indicate that the increase in resistance
predominantly occurred at the efferent glomerular arterioles
and that glomerular capillary pressure was maintained or ele-
vated despite reductions in RBF. In this situation it is reason-
able to speculate that the aforementioned abnormalities in
RBFA in ANG II HNa could eventually cause pressure-in-
duced glomerular injury. In addition, it may seem contradictory
that RVR was clearly increased in group ANG II HNa in view
of the impaired MR demonstrated by TF analysis. However, it
is important to recognize that impaired dynamic RBFA does
not indicate a certain level of RBF at a certain level of AP, but
more likely predicts whether the response of RBF following a
dynamic change in arterial pressure will be normal. In line with
Fig. 4. PSD for AP and RBF, and transfer function gain, phase, and coherence
in anesthetized Sprague-Dawley rats after 14 days of ANG II-infusion (250
ng·kg1·min1 sc) with or without tempol in drinking water (1 M). Rats were
on an HNa diet (see METHODS). Contrary to in ANG II HNa, there was, in group
ANG II HNatempol, a clear transition in gain from positive to negative
values in the frequency range of the MR, and this was associated with a local
maximum in phase, indicating an active MR. Values are means  SE.
Fig. 3. PSD for AP and RBF, and transfer function gain, phase, and coherence
in anesthetized Sprague-Dawley rats after 14 days of ANG II-infusion (250
ng·kg1·min1 sc) with or without tempol in drinking water (1 M). Rats were
on an NNa diet (see METHODS). Tempol did not significantly affect transfer
function variables. Values are means  SE.
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our results, Elmarakby et al. (13) showed that autoregulatory
responses of afferent arterioles to step-wise increases in per-
fusion pressure were blunted in ANG II-infused rats on high
dietary NaCl (13). However, in that study no comparison was
made to ANG II-infused animals on a normal NaCl intake.
Interestingly, Zhao et al. (41) investigated the effects of ANG
II and high-NaCl diet on afferent arteriolar responses to ace-
tylcholine and sodium nitroprusside by using the in vitro
blood-perfused juxtamedullary nephron preparation and found
that vasodilator responses were significantly more attenuated in
ANG II-infused rats on a high-NaCl diet compared with those
on a normal NaCl diet (41). Although RBFA was not assessed,
Table 3. Arterial and arteriolar changes in kidney cortex
Sham NNa Ang II NNa Ang II HNa Ang II NNa  Tempol Ang II HNa  Tempol
Arteriolar hyperplasia 0 1.25 0.16* 0.88  0.30* 0.63 0.18 0.50  0.19
Arteriolar hyalinosis 0 0.38 0.18 1.00  0.13* 0.50 0.27 0.62  0.33
Thickening of the intimal layer of arteries 0 0.13  0.13 0.13  0.13 0.38 0.18 0.13  0.13
Thickening of the media layer of arteries 0.12  0.13 1.50  0.27* 1.63  0.18* 1.38 0.38 1.25  0.25
Hyaline deposition/necrosis of arteries 0 1.00 0.27* 1.50  0.27* 1.38 0.42 0.88  0.30
Data are means SE. Semiquantitative assessment of cortical arteries and arterioles (i.e., afferent and efferent arterioles) was performed by using a scale from
0 to 3 (see METHODS). Kruskal-Wallis test was used to compare the groups: Sham NNa, Ang II NNa, and Ang II HNa. Mann-Whitney U-test was used to compare
group Ang II NNa vs. Ang II NNaTempol and group Ang II HNa vs. Ang II HNaTempol. Values are means  SE. *P  0.05 vs. Sham NNa.
Fig. 5. Renal cortical arteries and arterioles
in Sprague-Dawley rats after 14 days of
ANG II (250 ng·kg1·min1 sc) or saline
vehicle (sham) infusion with or without tem-
pol in drinking water (1 M). Rats were on
either an NNa- or HNa diet (see METHODS).
Top, left: sham NNa; top, right: ANG II NNa;
bottom, left: ANG II HNa; and bottom, right:
ANG II HNatempol. Black arrows indicate
arterioles, and green arrows indicate arteries.
Sections were stained with periodic acid-
Schiff. Magnification, 	200. All ANG II-
infused groups showed mild thickening of
intimal and medial layers and hyaline depo-
sition/necrosis of arteries. In addition, affer-
ent and efferent arterioles showed mild hy-
perplasia and hyalinosis.
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these results demonstrate that the combined influence of ANG
II and high-NaCl intake produces more pronounced abnormal-
ities in afferent arterioles, the main site of RBFA, than either
stimulus alone.
In the present study, tempol attenuated abnormalities in TF
gain values in the frequency ranges of the MR in ANG II HNa,
indicating an important role for O2· in the impaired autoreg-
ulatory response specifically under the circumstance of both
elevated ANG II and high-NaCl intake. However, tempol did
not restore gain values in group ANG II HNatempol back to
the normal levels seen in sham groups, but only to the levels
observed in group ANG II NNa. In addition, tempol reduced
AP only in ANG II HNa. In line with our results, previous
studies have demonstrated that in ANG II-infused animals,
high-NaCl intake further increased O2· generation and lipid
peroxidation compared with animals on a normal NaCl intake
(6, 22). The mechanisms by which tempol attenuated abnor-
malities in RBFA in ANG II HNa in the present study remain
to be elucidated. One might speculate that the AP reduction,
per se, could play a role as indicated by Inscho et al. (20) in
ANG II-infused rats on a normal NaCl diet. However, in the
present study, tempol clearly did not return AP to normal,
suggesting that other, pressure-independent mechanisms might
be involved. Interestingly, Sharma et al. (33) showed that
transforming growth factor-
1 markedly attenuated RBFA in
rats using the blood-perfused juxtamedullary nephron tech-
nique and that this was associated with increased arteriolar
O2· production (33). In addition, pretreatment with tempol
prevented the impairment in RBFA induced by transforming
growth factor-
1, indicating an important role for O2· (33)
similar to in our study.
Alternatively, one could speculate that tempol improved
dynamic RBFA in ANG II HNa in the present study by
reducing sympathetic nerve activity as suggested by a reduced
AP and heart rate in group ANG II HNatempol. Previous
studies have shown that chronic ANG II infusion increases
O2· formation in the rostral ventrolateral medulla (6) and
overall sympathetic activity (25) in rats on a high-NaCl diet
compared with rats on a normal NaCl diet. In addition, tempol
administered intracerebroventricularly prevents increases in
AP and renal sympathetic nerve activity (RSNA) in response to
ANG II injected intracerebroventricularly (7). Since it has
previously been demonstrated that vasoconstrictor intensities
of RSNA impair dynamic RBFA (12), it is possible that tempol
improved RBFA in the present study by reducing RSNA.
However, arguing against this hypothesis, Yoshimoto et al.
(39) have shown that although whole-body sympathetic activ-
ity is elevated in ANG II-infused rats on a high-NaCl diet,
RSNA is not.
In the present study, histological analyses showed modest
but significant arterial and arteriolar changes in the renal cortex
of both ANG II NNa and ANG II HNa. However, vascular
changes were of similar extent in both groups and were
unaffected by tempol. Although, dynamic RBFA was signifi-
cantly more impaired in ANG II HNa compared with ANG II
NNa, and attenuated by tempol, there was no correlation
between structural vascular changes and autoregulatory capac-
ity. Taken together, these findings indicate that abnormalities
in dynamic RBFA could not be explained by structural alter-
ations of the renal vasculature. Although impaired RBFA,
assessed at steady-state using step changes in renal perfusion
pressure has been shown to increase the susceptibility to
hypertensive glomerular injury (2, 17, 37, 38), impaired dy-
namic RBFA in ANG II HNa did not result in increased
glomerular injury as evidenced by semiquantitative analyses.
Possibly, the short duration of the experiment could explain the
limited glomerular changes. However, it is also possible that
steady-state and dynamic analyses of RBFA provide important
but different insights into the autoregulatory behavior of the
renal vascular bed (3, 16).
Noteworthy, ANG II-infused rats on a high-NaCl diet
showed significantly higher urinary water and Na excretion
rates compared with group sham HNa. Food and water intake
were not measured in the present study. However, as ANG II
is a very potent dipsogenic factor and also increases Na
appetite (14), it is reasonable to speculate that these effects of
ANG II could contribute to the observed increases in urinary
water and Na excretion in group ANG II HNa.
In conclusion, ANG II-infused rats on a high-NaCl diet
developed marked impairments in dynamic RBFA, mainly
affecting the MR, that were significantly more pronounced
than in rats on a normal NaCl diet. In addition, these abnor-
malities were attenuated by tempol, suggesting a pathogenetic
role for O2· in the impaired RBF autoregulatory response.
Perspectives and Significance
Hypertension is an important cause of kidney injury and
end-stage renal disease (19). However, the pathophysiological
mechanisms by which hypertension causes renal injury are
multiple and incompletely understood (13, 27, 28, 34). The
results of the present study suggest that a very high-NaCl
intake in ANG II-dependent forms of hypertension, in addition
to elevating AP further, could increase the susceptibility to
hypertensive glomerular injury by impairing RBFA. For in-
stance, in patients with renovascular hypertension and unilat-
eral renal artery stenosis, the avoidance of a high-NaCl intake
might protect the nonstenotic kidney from progressive glomer-
ular injury. Alternatively, pharmacological agents that target
O2· may exert renoprotective effects by attenuating abnor-
malities in RBFA in the same situation. It remains to be
investigated whether the effect of high-NaCl intake on RBFA
in ANG II-infused rats is specific for this model or relevant
also in other hypertensive states.
ACKNOWLEDGMENTS
The technical assistance of Elisabeth Grimberg is acknowledged.
GRANTS
This study was supported by grants from the Swedish Heart-Lung Foun-
dation, the Göteborg Medical Society, the Swedish Medical Society, the
Swedish Association for Kidney Patients, Swedish Society of Nephrology, and
Brit Wennerström’s Research Foundation.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
REFERENCES
1. Abu-Amarah I, Bidani AK, Hacioglu R, Williamson GA, Griffin KA.
Differential effects of salt on renal hemodynamics and potential pressure
transmission in stroke-prone and stroke-resistant spontaneously hyperten-
sive rats. Am J Physiol Renal Physiol 289: F305–F313, 2005.
R1148 DYNAMIC RENAL AUTOREGULATION IN ANG II-INFUSED RATS
AJP-Regul Integr Comp Physiol • VOL 299 • NOVEMBER 2010 • www.ajpregu.org
 by 10.220.33.4 on January 15, 2017
http://ajpregu.physiology.org/
D
ow
nloaded from
 
2. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R.
Protective importance of the myogenic response in the renal circulation.
Hypertension 54: 393–398, 2009.
3. Bidani AK, Hacioglu R, Abu-Amarah I, Williamson GA, Loutzen-
hiser R, Griffin KA. “Step” vs. “dynamic” autoregulation: implications
for susceptibility to hypertensive injury. Am J Physiol Renal Physiol 285:
F113–F120, 2003.
4. Bidani AK, Schwartz MM, Lewis EJ. Renal autoregulation and vulner-
ability to hypertensive injury in remnant kidney. Am J Physiol Renal Fluid
Electrolyte Physiol 252: F1003–F1010, 1987.
5. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM.
Microalbuminuria in salt-sensitive patients. A marker for renal and car-
diovascular risk factors. Hypertension 23: 195–199, 1994.
6. Braga VA. Dietary salt enhances angiotensin-II-induced superoxide for-
mation in the rostral ventrolateral medulla. Auton Neurosci 155: 14–18,
2010.
7. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angio-
tensin II-dependent stimulation of sympathetic nerve activity. Hyperten-
sion 46: 533–539, 2005.
8. Casellas D, Bouriquet N, Moore LC. Branching patterns and autoregu-
latory responses of juxtamedullary afferent arterioles. Am J Physiol Renal
Physiol 272: F416–F421, 1997.
9. Cupples WA, Braam B. Assessment of renal autoregulation. Am J
Physiol Renal Physiol 292: F1105–F1123, 2007.
10. DiBona GF. Dynamic analysis of patterns of renal sympathetic nerve
activity: implications for renal function. Exp Physiol 90: 159–161, 2005.
11. DiBona GF, Sawin LL. Effect of endogenous angiotensin II on the
frequency response of the renal vasculature. Am J Physiol Renal Physiol
287: F1171–F1178, 2004.
12. DiBona GF, Sawin LL. Effect of renal denervation on dynamic autoreg-
ulation of renal blood flow. Am J Physiol Renal Physiol 286: F1209–
F1218, 2004.
13. Elmarakby AA, Quigley JE, Olearczyk JJ, Sridhar A, Cook AK,
Inscho EW, Pollock DM, Imig JD. Chemokine receptor 2b inhibition
provides renal protection in angiotensin II - salt hypertension. Hyperten-
sion 50: 1069–1076, 2007.
14. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78:
583–686, 1998.
15. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators
of angiotensin II signaling. Regul Pept 91: 21–27, 2000.
16. Griffin KA, Hacioglu R, Abu-Amarah I, Loutzenhiser R, Williamson
GA, Bidani AK. Effects of calcium channel blockers on “dynamic” and
“steady-state step” renal autoregulation. Am J Physiol Renal Physiol 286:
F1136–F1143, 2004.
17. Griffin KA, Picken MM, Bidani AK. Deleterious effects of calcium
channel blockade on pressure transmission and glomerular injury in rat
remnant kidneys. J Clin Invest 96: 793–800, 1995.
18. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the devel-
opment of hypertensive renal injury in Dahl salt-sensitive rats. Am J
Hypertens 18: 707–713, 2005.
19. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated
blood pressure and risk of end-stage renal disease in subjects without
baseline kidney disease. Arch Intern Med 165: 923–928, 2005.
20. Inscho EW, Cook AK, Murzynowski JB, Imig JD. Elevated arterial
pressure impairs autoregulation independently of AT1 receptor activation.
J Hypertens 22: 811–818, 2004.
21. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan cilexetil
protects against loss of autoregulatory efficiency in angiotensin II-infused
rats. J Am Soc Nephrol 10, Suppl 11: S178–S183, 1999.
22. Johansson ME, Bernberg E, Andersson IJ, Bie P, Skott O, Gan LM,
Bergstrom G. High-salt diet combined with elevated angiotensin II
accelerates atherosclerosis in apolipoprotein E-deficient mice. J Hypertens
27: 41–47, 2009.
23. Just A. Mechanisms of renal blood flow autoregulation: dynamics and
contributions. Am J Physiol Regul Integr Comp Physiol 292: R1–R17,
2007.
24. Just A, Ehmke H, Wittmann U, Kirchheim HR. Role of angiotensin II
in dynamic renal blood flow autoregulation of the conscious dog. J Physiol
538: 167–177, 2002.
25. King AJ, Novotny M, Swain GM, Fink GD. Whole body norepinephrine
kinetics in ANG II-salt hypertension in the rat. Am J Physiol Regul Integr
Comp Physiol 294: R1262–R1267, 2008.
26. Koopmans LH. Preface. In: The Spectral Analysis of Time Series (2nd
ed.). San Diego, CA: Academic, 1995.
27. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Har-
rison DG. Role of superoxide in angiotensin II-induced but not cate-
cholamine-induced hypertension. Circulation 95: 588–593, 1997.
28. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregu-
lation: new perspectives regarding the protective and regulatory roles of
the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290:
R1153–R1167, 2006.
29. Nitescu N, Grimberg E, Guron G. Low-dose candesartan improves renal
blood flow and kidney oxygen tension in rats with endotoxin-induced
acute kidney dysfunction. Shock 30: 166–172, 2008.
30. Ogihara T, Asano T, Ando K, Chiba Y, Sakoda H, Anai M, Shojima
N, Ono H, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi
M, Noguchi N, Aburatani H, Komuro I, Fujita T. Angiotensin II-
induced insulin resistance is associated with enhanced insulin signaling.
Hypertension 40: 872–879, 2002.
31. Ploth DW. Angiotensin-dependent renal mechanisms in two-kidney, one-
clip renal vascular hypertension. Am J Physiol Renal Fluid Electrolyte
Physiol 245: F131–F141, 1983.
32. Sasser JM, Pollock JS, Pollock DM. Renal endothelin in chronic angio-
tensin II hypertension. Am J Physiol Regul Integr Comp Physiol 283:
R243–R248, 2002.
33. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-
 impairs
renal autoregulation via generation of ROS. Am J Physiol Renal Physiol
288: F1069–F1077, 2005.
34. Susic D, Zhou X, Frohlich ED. Angiotensin blockade prevents salt-
induced injury of the renal circulation in spontaneously hypertensive rats.
Am J Nephrol 29: 639–645, 2009.
35. Takenaka T, Forster H, De Micheli A, Epstein M. Impaired myogenic
responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res
71: 471–480, 1992.
36. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunc-
tion in salt-sensitive hypertension. Kidney Blood Press Res 24: 116–123,
2001.
37. Van Dokkum RP, Alonso-Galicia M, Provoost AP, Jacob HJ, Roman
RJ. Impaired autoregulation of renal blood flow in the fawn-hooded rat.
Am J Physiol Regul Integr Comp Physiol 276: R189–R196, 1999.
38. Wang X, Ajikobi DO, Salevsky FC, Cupples WA. Impaired myogenic
autoregulation in kidneys of Brown Norway rats. Am J Physiol Renal
Physiol 278: F962–F969, 2000.
39. Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic
angiotensin II infusion causes differential responses in regional sympathe-
tic nerve activity in rats. Hypertension 55: 664–651.
40. Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock
JS, Imig JD, Inscho EW. Impaired Ca2 signaling attenuates P2X
receptor-mediated vasoconstriction of afferent arterioles in angiotensin II
hypertension. Hypertension 46: 562–568, 2005.
41. Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD. Decreased renal
cytochrome P450 2C enzymes and impaired vasodilation are associated
with angiotensin salt-sensitive hypertension. Hypertension 41: 709–714,
2003.
R1149DYNAMIC RENAL AUTOREGULATION IN ANG II-INFUSED RATS
AJP-Regul Integr Comp Physiol • VOL 299 • NOVEMBER 2010 • www.ajpregu.org
 by 10.220.33.4 on January 15, 2017
http://ajpregu.physiology.org/
D
ow
nloaded from
 
